Article
Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer.
PloS one - 1 Jan 2014
Ó hAinmhire Eoghainín, Quartuccio Suzanne M, Cheng Whay, Ahmed Roshan A, King Shelby M, Burdette Joanna E
Abstract excerpt
Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome Atlas Network identified p53 mutations in 96% of high-grade serous ovarian carcinomas, demonstrating its critical role. Additionally, the Transforming Growth Factor Beta (TGFβ) pathway is dysfunctional in various malignancies, including ovarian cancer. This study investigated how expression of wild-type, mutant,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
